Physician profile
Ronald Hess
NPI 1023018348
$1,116.40
in general payments reported to CMS, 2019-2025
13 companies · $77.91 in 2025
The $77.91 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $41.82 · 2021: $275 · 2022: $206 · 2023: $35.27 · 2024: $341 · 2025: $77.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $445.72 | 2021-2024 | Senza |
| Depuy Synthes Sales INC. | $151.35 | 2024-2025 | Orthovisc, Monovisc |
| Boston Scientific Corporation | $140.43 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Stimwave Technologies Incorporated | $123.06 | 2019 | |
| Globus Medical, INC. | $48.86 | 2025 | Omnia, Vyrsa V1 |
| Medtronic, INC. | $45.45 | 2024-2025 | Intellis Adaptivestim, Rialto Si Fusion System |
| Bioventus LLC | $40.62 | 2020-2024 | Durolane |
| Legacy Ortho LLC | $29.69 | 2022 | |
| Smith+Nephew, INC. | $24.55 | 2020 | |
| Vericel Corporation | $21.37 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.99 | 2019 | |
| Saluda Medical Americas, INC. | $14.70 | 2024 | Evoke |
| Pacira Therapeutics, INC. | $14.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.